S100A7 in Psoriasis: Immunodetection and Activation by CRISPR technology.

Area of Science:

• Dermatology
• Immunology
• Molecular Biology

Background:

• Psoriasis is an inflammatory autoimmune skin disease driven by keratinocyte and immune cell interactions.
• The exact mechanisms of psoriasis pathogenesis are not fully understood, but involve genetic and environmental factors.
• S100A7 is overexpressed in psoriasis, suggesting a role in the disease, but its regulation and function are unclear.

Purpose of the Study:

• To investigate the role of S100A7 in psoriasis pathogenesis.
• To develop and describe methods for analyzing S100A7 expression.
• To provide insights into potential new therapeutic approaches for psoriasis.

Main Methods:

• Immunohistochemistry and immunofluorescence techniques were employed.
• Analysis was performed on psoriatic patient samples.
• S100A7 CRISPR-activated human keratinocyte cell line was utilized for experimental analysis.

Main Results:

• The study details methodologies for assessing S100A7 expression via immunohistochemistry and immunofluorescence.
• These methods were applied to psoriatic patient tissues and a specific cell line.
• The findings lay the groundwork for further research into S100A7's function in psoriasis.

Conclusions:

• Understanding S100A7 regulation and function is crucial for developing novel psoriasis treatments.
• Immunohistology is a valuable tool for elucidating psoriasis pathogenesis.
• The described methods facilitate the study of S100A7 in psoriasis models and patient samples.